Published in:
01-11-2020 | Acute Kidney Injury | Editorial Commentary
Role of pediatric nephrologists in managing adults with AKI due to COVID-19
Authors:
Marissa Lipton, Catherine R. Kavanagh, Ruchi Mahajan, Namrata G. Jain, Natalie S. Uy, Samriti Dogra, Fangming Lin
Published in:
Pediatric Nephrology
|
Issue 11/2020
Login to get access
Excerpt
To date, SARS-CoV-2 virus has infected over 7 million people and claimed more than 400,000 lives worldwide. In addition to pneumonia and respiratory failure, the disease also causes multiple organ injuries including the kidney [
1]. Although the true incidence of acute kidney injury (AKI) at the global level is currently unknown, observational studies in Wuhan City of China report that 25–30% of critically ill patients suffered from AKI [
2,
3]. Similarly, data from patients admitted to the hospitals in New York City, the epicenter of COVID-19 in the USA, show that about 30% developed AKI. More strikingly, 75% of ICU patients had AKI and 31% required renal replacement therapy (Argenziano et al., medRxiv, April 20, 2020). Furthermore, a high death rate is observed when AKI is more severe [
4]. This resulted in an unprecedented shortage of dialysis equipment, supplies, and care providers. …